NBTX

Q: What is the price of Nanobiotix (NBTX) today?

The current price of Nanobiotix (NBTX) is $ 49.48, representing a 1181.87% gain over the past year. The stock began the year trading around $ 23.12 and is currently priced at $ 49.48. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Nanobiotix (NBTX) pay dividends?

Nanobiotix (NBTX) did not pay dividends over the past year.

Q: Is Nanobiotix (NBTX) a good investment?

Nanobiotix (NBTX) is currently trading at $ 49.48 with a P/E ratio of -113.65. This represents a -75,002,841% premium compared to its historical average P/E. Over the past year, the stock has gained 1181.87 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 1,181.87%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Nanobiotix S.A.

Price

$ 49.48

return (12m)

1,181.87%

p/e

-113.65

p/bv

-24.99

DIVIDEND YIELD

0.00%

NBTX price

NBTX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment NBTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

46.43%

3 months

84.01%

1 year

1,181.87%

2 years

584.37%

5 years

220.47%

10 years

0.00%

Fundamentals NBTX

review the fundamentals of Nanobiotix shares

P/E

-113.65

Sector: -9.59 Industry: -9.59

P/S (PSR)

447.82

Sector: -138.14 Industry: -138.14

P/BV

-24.99

Sector: 1.99 Industry: 1.99

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-27.41%

Sector: -31.16% Industry: -31.16%

ROE

21.99%

Sector: -31.19% Industry: -31.19%

ROIC

-49.05%

Sector: -2,596.17% Industry: -2,596.17%

NET MARGIN

-100.00%

Sector: -39.99% Industry: -39.99%

GROSS MARGIN

100.00%

Sector: 37.30% Industry: 37.30%

OPERATING MARGIN

-100.00%

Sector: -39.14% Industry: -39.14%

EV/EBITDA

-179.91

Sector: -10.69 Industry: -10.69

EV/EBIT

-169.90

Sector: -10.50 Industry: -10.50

PRICE-TO-ASSETS

31.16

Sector: 1.43 Industry: 1.43

BVPS

-2.06

Sector: 1.96 Industry: 1.96

EPS

-0.45

Sector: -1.07 Industry: -1.07

EQUITY-TO-ASSETS RATIO

-1.25

Sector: 0.44 Industry: 0.44

LIABILITIES / ASSETS

2.25

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

367.33%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

12.53%

Sector: - Industry: -

Fundamentals NBTX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	103.71	6.69	6.45%	2.31%	$ 542.92 B	21.76%
PFE	52.78	1.57	2.97%	6.90%	$ 141.82 B	18.60%
ABBV	535.81	-56.32	-10.51%	3.20%	$ 372.39 B	4.63%
NVO	26.47	6.33	23.91%	4.17%	$ 198.78 B	50.15%
AZN	91.32	5.94	6.50%	1.76%	$ 281.27 B	20.15%
GILD	79.63	6.87	8.63%	2.46%	$ 160.94 B	29.04%
BMY	43.39	5.78	13.32%	4.39%	$ 116.17 B	23.30%
ZTS	52.11	9.69	18.59%	2.74%	$ 31.32 B	26.57%
REGN	99.86	2.31	2.31%	0.51%	$ 72.62 B	20.17%
HALO	52.78	36.06	68.32%	0.00%	$ 7.92 B	39.83%
AMGN	96.87	19.17	19.79%	2.96%	$ 176.21 B	21.11%
MCK	55.17	-111.26	-201.68%	0.42%	$ 92.79 B	1.75%
HRMY	53.72	1.92	3.57%	0.00%	$ 1.75 B	15.08%
VRTX	107.61	5.73	5.33%	0.00%	$ 110.99 B	34.53%
CAH	114.64	-17.12	-14.93%	1.05%	$ 45.74 B	0.65%
ADMA	43.06	5.00	11.61%	0.00%	$ 1.95 B	39.59%
BIIB	88.77	1.52	1.71%	0.00%	$ 28.36 B	12.89%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*The value considers the reinvestment of dividends.

NBTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Nanobiotix

Nanobiotix S.A.

Average Investor10 user rating

4.0 (2 people)

United States

23 years

Founded: 2003

2020

Time since IPO - 6 years

88

Employees

Nanobiotix S.A. (United States) is listed on the Nasdaq and has a market capitalization of $2.47 Billions, with shareholders equity totaling $-98.93 Millions.

The company employs approximately 88 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Nanobiotix S.A. reported $22.29 Millions in revenue, generating net income of $-99.94 Millions.

Key financial metrics include a P/E ratio of -113.65, a price-to-book (P/B) ratio of -24.99, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NBTX.

Market cap

$ 2.47 Billions

Net worth

$ -98.93 Millions

$ -98,930,000.00

Assets

$ 79.34 Millions

$ 79,340,000.00

Total Shares Outstanding

48.00 Millions

48,000,000

Average Daily Trading Volume

$ 82.15 Thousand

$ 82,146.58

Sector

Health Care

Industry

Biotechnology

NBTX

NBTX revenue and profits

Financial Results NBTX

DRAG THE FRAME TO SEE MORE DATA

NBTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$ 775.97 7,36% (12M)

P/E

55.17

0.42%

ROE

-201.68%

P/BV

-111.26

CAH - Cardinal Health

$ 199.77 31,67% (12M)

P/E

114.64

1.05%

ROE

-14.93%

P/BV

-17.12

JNJ - Johnson & Johnson

$ 228.92 55,22% (12M)

P/E

103.71

2.31%

ROE

6.45%

P/BV

6.69

MRK - Merck & Co.

$ 112.56 51,01% (12M)

P/E

-64.94

2.98%

ROE

-9.23%

P/BV

5.99

AZN - AstraZeneca

$ 183.92 33,83% (12M)

P/E

91.32

1.76%

ROE

6.50%

P/BV

5.94

ABBV - AbbVie

$ 209.41 16,34% (12M)

P/E

535.81

3.20%

ROE

-10.51%

P/BV

-56.32

NVO - Novo Nordisk

$ 44.28 --30,73% (12M)

P/E

26.47

4.17%

ROE

23.91%

P/BV

6.33

BFRA - Biofrontera

$ - -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$ 775.97 7,36% (12 M)

P/L

55.17

0.42%

ROE

-201.68%

P/VP

-111.26

CAH - Cardinal Health

$ 199.77 31,67% (12 M)

P/L

114.64

1.05%

ROE

-14.93%

P/VP

-17.12

JNJ - Johnson & Johnson

$ 228.92 55,22% (12 M)

P/L

103.71

2.31%

ROE

6.45%

P/VP

6.69

MRK - Merck & Co.

$ 112.56 51,01% (12 M)

P/L

-64.94

2.98%

ROE

-9.23%

P/VP

5.99

AZN - AstraZeneca

$ 183.92 33,83% (12 M)

P/L

91.32

1.76%

ROE

6.50%

P/VP

5.94

ABBV - AbbVie

$ 209.41 16,34% (12 M)

P/L

535.81

3.20%

ROE

-10.51%

P/VP

-56.32

NVO - Novo Nordisk

$ 44.28 --30,73% (12 M)

P/L

26.47

4.17%

ROE

23.91%

P/VP

6.33

Frequently Asked Questions

What is the price of Nanobiotix (NBTX) today?

The current price of Nanobiotix (NBTX) is $ 49.48, representing a 1181.87% gain over the past year. The stock began the year trading around $ 23.12 and is currently priced at $ 49.48. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Nanobiotix (NBTX) pay dividends?

Nanobiotix (NBTX) did not pay dividends over the past year.

Is Nanobiotix (NBTX) a good investment?

Nanobiotix (NBTX) is currently trading at $ 49.48 with a P/E ratio of -113.65. This represents a -75,002,841% premium compared to its historical average P/E. Over the past year, the stock has gained 1181.87 and paid $ 0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was 1,181.87%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Nanobiotix (NBTX) stock?

You can buy Nanobiotix (NBTX) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol NBTX and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Nanobiotix (NBTX) yield today?

Over the past month, Nanobiotix (NBTX) has returned 46.43% — 1,181.87% over the past year, and 220.47% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Nanobiotix (NBTX) today at the current price of $ 49.48 your total investment would be $ 4,948.00.

Based on historical performance, the investment would have grown to approximately:

$ 63,426.93 after 1 year
$ 15,856.86 after 5 years
$ 4,948.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NBTX

Nanobiotix S.A.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NBTX

review the fundamentals of Nanobiotix shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Nanobiotix

Nanobiotix S.A.

United States

23 years

2020

88

PROFIT X PRICE NBTX

Financial Results NBTX

NBTX cash flow

Asset, Revenue and Profit Growth - NBTX

NBTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

AZN - AstraZeneca

ABBV - AbbVie

NVO - Novo Nordisk

Frequently Asked Questions